Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.670 | 0.670 | 0.000 |
Stocks | 98.610 | 98.610 | 0.000 |
Other | 0.720 | 0.720 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.383 | 14.182 |
Price to Book | 2.012 | 2.054 |
Price to Sales | 1.367 | 1.421 |
Price to Cash Flow | 10.207 | 9.407 |
Dividend Yield | 3.770 | 3.421 |
5 Years Earnings Growth | 12.320 | 10.023 |
Name | Net % | Category Average |
---|---|---|
Industrials | 20.470 | 16.730 |
Financial Services | 19.890 | 18.218 |
Healthcare | 12.490 | 14.969 |
Consumer Cyclical | 10.220 | 9.912 |
Consumer Defensive | 9.330 | 10.930 |
Basic Materials | 7.450 | 6.545 |
Technology | 5.590 | 9.121 |
Utilities | 5.550 | 4.573 |
Communication Services | 5.310 | 5.227 |
Real Estate | 3.710 | 1.945 |
Number of long holdings: 196
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.66 | 589.2 | -20.72% | |
ASML Holding | NL0010273215 | 2.69 | 686.10 | -0.68% | |
Novartis | CH0012005267 | 2.68 | 86.72 | -0.37% | |
AstraZeneca | GB0009895292 | 2.38 | 10,256.0 | +0.12% | |
Schneider Electric | FR0000121972 | 1.98 | 239.75 | -0.37% | |
Terna | IT0003242622 | 1.97 | 7.610 | +0.53% | |
HSBC | GB0005405286 | 1.90 | 760.80 | -0.56% | |
ABB | CH0012221716 | 1.66 | 48.86 | +0.27% | |
L'Oreal | FR0000120321 | 1.50 | 336.95 | -0.71% | |
Zurich Insurance Group | CH0011075394 | 1.49 | 533.00 | -0.97% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DK0060747822 | 6.61B | 25.47 | 9.66 | - | ||
DK0060747905 | 4B | 22.93 | 7.34 | - | ||
DK0060748200 | 937.19M | 29.13 | 9.77 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review